© 2020 MJH Life Sciences and Urology Times. All rights reserved.
© 2020 MJH Life Sciences™ and Urology Times. All rights reserved.
July 07, 2020
BLC with hexaminolevulinate can be an easily replicable procedure
in patients with non–muscle-invasive bladder cancer.
August 18, 2020
Next-generation sequencing identifies subtypes that may benefit from immune checkpoint inhibitors.
August 19, 2020
Combination therapy is the first-line standard for metastatic renal cell carcinoma.
Patients with cancer are particularly susceptible to negative consequences of COVID-19.
August 21, 2020
Urologists and patients show resilience, but we must be better prepared in the future, says urologist R. Jonathan Henderson, MD.